Home LiteratureArticle Details
PMID: 6494022 Published · ppublish English Journal Article

Quantification of the permeability of the blood-CSF barrier to alpha-MSH in the rat.

Peptides ·Vol. 5 ·No. 4 ·1984-00-00 ·Pages 681-5

Wilson JF, Anderson S, Snook G, Llewellyn KD

Abstract

The ability of alpha-MSH to cross the blood-CSF barrier of the rat was assessed by measurement of the rate of appearance of immunoreactive alpha-MSH in a cerebrospinal fluid (CSF) perfusate following intravenous injection of peptide. Comparisons were made with the rate of appearance of a simultaneously administered dose of 14C-inulin which is poorly permeable at the blood-CSF barrier. Concentrations of drugs measured in plasma were fitted to two-compartment pharmacokinetic models, and those measured in the CSF perfusate to one-compartment open systems receiving an input from the plasma compartment. The rate constant for entry of alpha-MSH into CSF was 0.00087 min-1, which was not significantly different from that for inulin of 0.00055 min-1. As alpha-MSH penetrated into CSF at a rate comparable to inulin, it was concluded that the limited entry of peptide was by aqueous diffusion along with other water-soluble macromolecules.

MeSH Terms
Animals Injections, Intravenous Inulin Kinetics Male Melanocyte-Stimulating Hormones/administration & dosage,blood,cerebrospinal fluid Permeability Rats Rats, Inbred Strains
Chemicals
Melanocyte-Stimulating Hormones Inulin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wilson J F
Anderson S
Snook G
Llewellyn K D
Article Info
Journal
Peptides
Abbr.
Peptides
ISSN
0196-9781
Published
1984-00-00
Pages
681-5
Language
English
Region
United States
NLM ID
8008690
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com